Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfoliosEvents
    Companies/GLSI

    Greenwich LifeSciences, Inc.(GLSI)

    Biotechnology
    Oncology Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    CVM
    87    LLY
    71    MRNA
    54    GLSI
    50    IOVA
    50    MRK
    50    BMY
    50    INAB
    50    AMGN
    44    JNJ
    40    GILD
    37
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeShares ownedAvg. PriceValueFiling
    2026-01-15
    Patel Snehal
    CEO and CFO
    Purchase
    		+1,800
    +0.03%5,750,822
    		$29.83$53,694View SEC filing
    2026-01-14
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,900
    +0.05%5,749,022
    		$27.54$79,866View SEC filing
    2026-01-05
    Patel Snehal
    CEO and CFO
    Purchase
    		+4,300
    +0.07%5,746,122
    		$21.36$91,848View SEC filing
    2026-01-02
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,900
    +0.05%5,741,822
    		$21.73$63,017View SEC filing
    2025-12-19
    Patel Snehal
    CEO and CFO
    Purchase
    		+4,100
    +0.07%5,738,922
    		$12.62$51,742View SEC filing
    2025-11-28
    Patel Snehal
    CEO and CFO
    Purchase
    		+4,600
    +0.08%5,734,822
    		$8.37$38,502View SEC filing
    2025-11-12
    Patel Snehal
    CEO and CFO
    Purchase
    		+10,600
    +0.19%5,730,222
    		$8.43$89,358View SEC filing
    2025-11-04
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,300
    +0.04%5,719,622
    		$9.26$21,298View SEC filing
    2025-04-29
    Patel Snehal
    CEO and CFO
    Purchase
    		+3,600
    +0.06%5,717,322
    		$9.88$35,568View SEC filing
    2025-04-22
    Patel Snehal
    CEO and CFO
    Purchase
    		+5,400
    +0.09%5,713,722
    		$8.98$48,492View SEC filing
    2025-04-08
    Patel Snehal
    CEO and CFO
    Purchase
    		+3,600
    +0.06%5,708,322
    		$9.10$32,760View SEC filing
    2025-04-07
    Patel Snehal
    CEO and CFO
    Purchase
    		+5,500
    +0.10%5,704,722
    		$8.73$48,015View SEC filing
    2025-01-13
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,500
    +0.04%5,699,222
    		$12.51$31,275View SEC filing
    2025-01-08
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,900
    +0.05%5,696,722
    		$13.58$39,391View SEC filing
    2025-01-07
    Patel Snehal
    CEO and CFO
    Purchase
    		+3,400
    +0.06%5,693,822
    		$12.95$44,030View SEC filing
    2025-01-06
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,000
    +0.04%5,690,422
    		$11.97$23,940View SEC filing
    2025-01-03
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,400
    +0.04%5,688,422
    		$11.36$27,264View SEC filing
    2025-01-02
    Patel Snehal
    CEO and CFO
    Purchase
    		+3,200
    +0.06%5,686,022
    		$11.12$35,584View SEC filing
    2024-11-25
    Thompson Jaye
    VP Clinical Reg Affairs
    Purchase
    		+1,000
    +0.38%264,148
    		$12.91$12,910View SEC filing
    2024-09-30
    Patel Snehal
    CEO and CFO
    Purchase
    		+1,500
    +0.03%5,536,102
    		$14.63$21,945View SEC filing
    2024-09-16
    Thompson Jaye
    VP Clinical Reg Affairs
    Purchase
    		+800
    +0.30%263,148
    		$13.85$11,080View SEC filing
    2024-08-08
    Patel Snehal
    CEO and CFO
    Purchase
    		+2,000
    +0.04%5,534,602
    		$13.81$27,620View SEC filing
    2024-08-07
    Patel Snehal
    CEO and CFO
    Purchase
    		+5,500
    +0.10%5,532,602
    		$13.18$72,490View SEC filing
    2024-08-05
    Thompson Jaye
    VP Clinical Reg Affairs
    Purchase
    		+1,000
    +0.38%262,348
    		$15.15$15,150View SEC filing
    2024-07-24
    Patel Snehal
    CEO and CFO
    Purchase
    		+1,500
    +0.03%5,527,102
    		$15.89$23,835View SEC filing

    1-25 of 115

    Page 1 of 5